Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Metabolon Advances the Understanding of Inflammation and Inflammatory Response with New Oxysterols Targeted Panel 2022-10-25 20:03
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines 2022-10-25 20:00
Clarivate Identifies Seven Innovators in New RNA Technology Companies to Watch Report 2022-10-25 15:19
MiRXES collaborates with Plug and Play to launch Southeast Asia's first science-backed commercialization engine and validator program 2022-10-25 11:50
T-cells treated by Turn Biotechnologies show increased cancer-killing effectiveness 2022-10-24 23:30
deCODE genetics publishes multiomics study of nonalcoholic fatty liver disease 2022-10-24 23:00
Transcenta to Participate in Four Upcoming Conferences 2022-10-24 21:00
Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences 2022-10-24 21:00
WuXi Biologics Released a New cGMP Drug Product Manufacturing Facility to Support End-to-End Services for Diversified Modalities 2022-10-24 08:30
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults 2022-10-22 03:25
Antengene Announces XPOVIO® Regulatory Approval in Taiwan for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma 2022-10-21 20:37
SIRONA completes enrollment - A leap in the DCB treatment of femoropopliteal arterial disease 2022-10-21 20:36
SK bioscience Appoints New Executives towards Global Business Growth 2022-10-21 20:00
MGI Contributes to Thailand's Roadmap for Genomic Medicine in Genomics Thailand Initiative 2022-10-21 11:00
AUM Biosciences and Asymchem Complete Phase II API Production Campaign of Novel TRK Inhibitor 2022-10-20 20:30
Official Ground-breaking Ceremony of Wuhan Synthetic Biology Innovation Center & CABIO R&D Center Investment Project 2022-10-20 20:30
Harbour BioMed Announces Dosing of First Patient in Phase I Trial of B7H4x4-1BB Bispecific Antibody in the United States 2022-10-20 16:20
BGI Australia Receives NATA Certification for Clinical Whole Exome Sequencing 2022-10-20 15:31
BGI Australia Receives NATA Certification for Clinical Whole Exome Sequencing 2022-10-20 15:27
AASLD 2022 | Ascentage Pharma to Announce Results from First-in-Human Study of IAP Antagonist APG-1387 in an Oral Report at the AASLD Annual Meeting 2022-10-20 07:16
1 147 148 149 150 151 453